| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100717900 |
| P356 | DOI | 10.1186/S12885-018-4022-5 |
| P932 | PMC publication ID | 5793406 |
| P698 | PubMed publication ID | 29386014 |
| P2093 | author name string | James V Pottala | |
| Satoshi Nagata | |||
| Kristi A Egland | |||
| Rick L Evans | |||
| P2860 | cites work | Clinical and molecular complexity of breast cancer metastases | Q26796326 |
| Cancer treatment and survivorship statistics, 2012 | Q27020961 | ||
| Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab | Q27640593 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Repeated observation of breast tumor subtypes in independent gene expression data sets | Q28131820 | ||
| Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay | Q30771030 | ||
| Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins | Q30882620 | ||
| Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display | Q31038778 | ||
| High expression of a cytokeratin-associated protein in many cancers | Q33238565 | ||
| Use of autoantibodies to detect the onset of breast cancer | Q34037876 | ||
| Tumor-associated autoantibodies as diagnostic and prognostic biomarkers | Q34049184 | ||
| Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer. | Q34347517 | ||
| A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases | Q35009135 | ||
| Promoting quality and evidence-based care in early-stage breast cancer follow-up | Q35029380 | ||
| Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis | Q35059164 | ||
| Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens | Q35123700 | ||
| Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer | Q35244082 | ||
| Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer | Q35750767 | ||
| Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer | Q36611827 | ||
| GRP78 induction in cancer: therapeutic and prognostic implications. | Q36794164 | ||
| Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer | Q37098938 | ||
| Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis | Q37141797 | ||
| Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. | Q37213540 | ||
| The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies | Q37285838 | ||
| Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer | Q37331132 | ||
| Current approaches and challenges in early detection of breast cancer recurrence | Q37695256 | ||
| 1st International consensus guidelines for advanced breast cancer (ABC 1). | Q37994463 | ||
| Autoantibodies in breast cancer. | Q38220961 | ||
| Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu | Q40130311 | ||
| Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum | Q40200746 | ||
| BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum | Q40648732 | ||
| Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen | Q40747388 | ||
| Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma | Q42447000 | ||
| Potential impact of USPSTF recommendations on early diagnosis of breast cancer | Q43493063 | ||
| Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer | Q43497337 | ||
| Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera. | Q46838881 | ||
| Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. | Q51774980 | ||
| Breast Cancer Metastasis: Challenges and Opportunities | Q57591118 | ||
| Autoantibodies in breast cancer: their use as an aid to early diagnosis | Q79905914 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 119 | |
| P577 | publication date | 2018-01-31 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality | |
| P478 | volume | 18 |
| Q93053380 | Assessing the interactions between radiotherapy and antitumour immunity |
| Q57109579 | Autoantibodies as Potential Biomarkers in Breast Cancer |
| Q92980058 | Impact of GFRA1 gene reactivation by DNA demethylation on prognosis of patients with metastatic colon cancer |
| Q89952897 | Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma |
Search more.